AFILALO MARC ET AL: "Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Study", CLINICAL DRUG INVESTIGATION, ADIS INTERNATIONAL, AUCKLAND, NZ, vol. 30, no. 8, 1 August 2010 (2010-08-01) , pages 489-505, XP009148168, ISSN: 1173-2563, DOI: DOI:10.2165/11533440-000000000-00000 (B1)

ILONA STEIGERWALD ET AL: "Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study", JOURNAL OF PAIN RESEARCH, 1 June 2012 (2012-06-01), page 121, XP055564495, DOI: 10.2147/JPR.S30540 (B1)

Ingvar Bjelland ET AL: "The validity of the Hospital Anxiety and Depression Scale. An updated literature review", Journal of psychosomatic research, 1 February 2002 (2002-02-01), pages 69-77, XP55421094, England DOI: 10.1016/S0022-3999(01)00296-3 Retrieved from the Internet: URL:https://www.sciencedirect.com/science/ article/pii/S0022399901002963 (B1)

SCHWARTZ SHERWYN ET AL: "Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.", CURRENT MEDICAL RESEARCH AND OPINION JAN 2011 LNKD- PUBMED:21162697, vol. 27, no. 1, January 2011 (2011-01), pages 151-162, XP009150479, ISSN: 1473-4877 (B1)

KUPERWASSER B ET AL: "337 HEALTH STATUS OF PATIENTS WHO RECEIVED TAPENTADOL PROLONGED RELEASE DURING AN OPEN-LABEL EXTENSION STUDY", OSTEOARTHRITIS AND CARTILAGE, BAILLIERE TINDALL, LONDON, GB, vol. 18, 1 October 2010 (2010-10-01), page S149, XP027316893, ISSN: 1063-4584 [retrieved on 2010-09-29] (B1)

LANGE R ET AL: "333 SHORT FORM-36 (SF-36) AND EUROQOL-5 DIMENSION (EQ-5D) RESULTS FROM RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDIES OF TAPENTADOL PROLONGED RELEASE (PR) IN PATIENTS WITH MODERATE TO SEVERE CHRONIC NOCICEPTIVE AND NEUROPATHIC PAIN", OSTEOARTHRITIS AND CARTILAGE, BAILLIERE TINDALL, LONDON, GB, vol. 18, 1 October 2010 (2010-10-01), pages S147-S148, XP027316889, ISSN: 1063-4584 [retrieved on 2010-09-29] (B1)

KUPERWASSER B ET AL: "337 EVALUATION OF LONG-TERM TREATMENT WITH TAPENTADOL EXTENDED RELEASE AND OXYCODONE CONTROLLED RELEASE IN PATIENTS WITH CHRONIC LOW BACK OR OSTEOARTHRITIS PAIN: RESULTS FROM PATIENT AND PHYSICIAN GLOBAL ASSESSMENTS AND THE EUROQOL 5 DIMENSION QUESTIONNAIRE", OSTEOARTHRITIS AND CARTILAGE, BAILLIERE TINDALL, LONDON, GB, vol. 17, 1 September 2009 (2009-09-01), page S179, XP026582221, ISSN: 1063-4584, DOI: DOI:10.1016/S1063-4584(09)60359-9 [retrieved on 2009-09-01] (B1)